ethidium has been researched along with sapropterin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagi, Z; Kaley, G; Koller, A; Toth, E | 1 |
| Boucher, JL; Brunet, A; David-Dufilho, M; Devynck, MA; Millanvoye, E; Rendu, F; Topal, G | 1 |
2 other study(ies) available for ethidium and sapropterin
| Article | Year |
|---|---|
Microvascular dysfunction after transient high glucose is caused by superoxide-dependent reduction in the bioavailability of NO and BH(4).
Topics: Animals; Arterioles; Biological Availability; Biopterins; Carotid Arteries; Dose-Response Relationship, Drug; Ethidium; Glucose; In Vitro Techniques; Indicators and Reagents; Male; Muscle, Skeletal; Nitric Oxide; Pressure; Rats; Rats, Wistar; Regional Blood Flow; Superoxides; Vasodilation | 2004 |
Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin.
Topics: Antioxidants; Arginine; Ascorbic Acid; Biopterins; Blotting, Western; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethidium; Fluorescent Dyes; Homocysteine; Humans; L-Lactate Dehydrogenase; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorylation; Pterins; Reactive Nitrogen Species; Superoxides; Thrombin; Time Factors | 2004 |